LFVN

MKT CAP:$65M

LifeVantage Corporation

Market Cap

$65M

Consumer Defensive·Packaged Foods·🇺🇸 United States·NASDAQ

Consumer Def.·Packaged Foods·🇺🇸·NASDAQ

Stock Price

$5.17-$0.86 (-14.26%)

Apr 24, 2026

Company Details

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care produ...

CEO

Steven R. Fife

IPO Date

Apr 7, 1994

Website

www.lifevantage.com

Key Metrics TTM

Revenue

$210M

-3.5% YoY

Net Income

$8M

EPS (Diluted)

$0.60

Free Cash Flow

$2M

Revenue / Share

$16.48

Gross Margin

78.7%

Operating Margin

4.3%

Net Margin

3.7%

FCF Margin

0.8%

P/S

0.3x

P/E

8.3x

Earnings Reports

Q3 2026

May 5, 2026

PENDING

Q2 2026

Feb 4, 2026

$49M-27.8%EPS $0.02

Q1 2026

Nov 4, 2025

$48M+0.7%EPS $0.17

FY 2025

Sep 4, 2025

$229M+14.2%EPS $0.76

Q4 2025

Sep 4, 2025

$55M+12.6%EPS $0.15

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$52M	$43M	$2M
Q4 21	$55M	$45M	$7M
Q1 22	$53M	$44M	$5M
Q2 22	$52M	$43M	-$358.0K
Q3 22	$50M	$40M	$2M
Q4 22	$51M	$42M	$1M
Q1 23	$52M	$42M	$1M
Q2 23	$54M	$42M	-$1M
Q3 23	$54M	$43M	$2M
Q4 24	$49M	$39M	$3M
Q1 25	$47M	$38M	$3M
Q2 25	$68M	$55M	$3M
Q3 25	$58M	$47M	$4M
Q4 25	$55M	$44M	$2M
Q1 26	$48M	$38M	$2M
Q2 26	$49M	$36M	$487.0K

Valuation

Quarter	P/S	P/E
Q3 21	0.3x	5.5x
Q4 21	0.3x	5.0x
Q1 22	0.3x	4.7x
Q2 22	0.3x	6.5x
Q3 22	0.3x	6.9x
Q4 22	0.3x	20.8x
Q1 23	0.3x	156.8x
Q2 23	0.3x	—
Q3 23	0.3x	—
Q4 24	0.3x	34.6x
Q1 25	0.3x	21.0x
Q2 25	0.3x	9.7x
Q3 25	0.3x	7.1x
Q4 25	0.3x	6.6x
Q1 26	0.3x	6.4x
Q2 26	0.3x	8.3x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 21	$3M	$1M
Q4 21	$8M	$8M
Q1 22	$465.0K	$87.0K
Q2 22	$4M	$4M
Q3 22	$671.0K	$306.0K
Q4 22	$3M	$3M
Q1 23	-$1M	-$2M
Q2 23	$967.0K	$130.0K
Q3 23	$3M	$2M
Q4 24	$3M	$2M
Q1 25	-$583.0K	-$932.0K
Q2 25	$9M	$9M
Q3 25	$2M	$2M
Q4 25	$1M	$835.0K
Q1 26	-$2M	-$3M
Q2 26	$3M	$2M

Capital Expenditures

Quarter	CapEx
Q3 21	$2M
Q4 21	$480.0K
Q1 22	$378.0K
Q2 22	$521.0K
Q3 22	$365.0K
Q4 22	$266.0K
Q1 23	$727.0K
Q2 23	$837.0K
Q3 23	$990.0K
Q4 24	$278.0K
Q1 25	$349.0K
Q2 25	$492.0K
Q3 25	$331.0K
Q4 25	$199.0K
Q1 26	$439.0K
Q2 26	$1M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	-8.0%	-6.7%
Q4 21	-7.7%	-9.3%
Q1 22	-2.9%	-5.3%
Q2 22	-11.6%	-1.9%
Q3 22	-3.0%	-2.6%
Q4 22	-7.0%	+2.6%
Q1 23	-2.7%	+3.9%
Q2 23	+2.8%	+4.5%
Q3 23	+7.5%	+8.2%
Q4 24	-3.9%	-6.9%
Q1 25	-8.8%	-11.6%
Q2 25	+26.3%	+17.2%
Q3 25	+8.7%	+4.3%
Q4 25	+12.6%	+15.1%
Q1 26	+0.7%	+1.5%
Q2 26	-27.8%	-24.7%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 21	$668.0K	1.3%
Q4 21	-$79.0K	-0.1%
Q1 22	$645.0K	1.2%
Q2 22	$755.0K	1.4%
Q3 22	-$38.0K	-0.1%
Q4 22	$406.0K	0.8%
Q1 23	$602.0K	1.2%
Q2 23	$823.0K	1.5%
Q3 23	$817.0K	1.5%
Q4 24	$756.0K	1.5%
Q1 25	$917.0K	1.9%
Q2 25	$2M	2.5%
Q3 25	$2M	2.6%
Q4 25	$2M	2.8%
Q1 26	$826.0K	1.7%
Q2 26	$553.0K	1.1%

OpEx Breakdown

Quarter	G&A	S&M	SG&A
Q3 21	$16M	$25M	—
Q4 21	$13M	$26M	—
Q1 22	$15M	$24M	—
Q2 22	$17M	$25M	—
Q3 22	$15M	$23M	—
Q4 22	$16M	$25M	—
Q1 23	$17M	$24M	—
Q2 23	$20M	$24M	—
Q3 23	$18M	$24M	—
Q4 24	$14M	—	—
Q1 25	$15M	—	—
Q2 25	$19M	—	—
Q3 25	$17M	—	—
Q4 25	$19M	—	—
Q1 26	—	—	$15M
Q2 26	$16M	—	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 22	$18M	$0	$18M
Q4 22	$20M	$0	$20M
Q1 23	$18M	$0	$18M
Q2 23	$17M	$0	$17M
Q3 23	$20M	$0	$20M
Q4 23	$22M	$0	$22M
Q1 24	$18M	$0	$18M
Q2 24	$17M	$0	$17M
Q3 24	$17M	$0	$17M
Q4 24	$17M	$0	$17M
Q1 25	$15M	$0	$15M
Q2 25	$15M	$0	$15M
Q3 25	$22M	$0	$22M
Q4 25	$22M	$0	$22M
Q1 26	$13M	$0	$13M
Q2 26	$10M	$0	$10M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	14M	-1.6%	-3.2%
Q4 21	14M	-2.3%	-5.6%
Q1 22	13M	-3.0%	-8.3%
Q2 22	13M	-1.4%	-8.0%
Q3 22	13M	-0.2%	-6.7%
Q4 22	12M	-5.8%	-10.0%
Q1 23	12M	+0.1%	-7.2%
Q2 23	13M	+0.4%	-5.6%
Q3 23	13M	+1.8%	-3.7%
Q4 24	13M	+1.1%	+3.3%
Q1 25	13M	-0.6%	+2.6%
Q2 25	13M	+2.8%	+5.1%
Q3 25	13M	+0.9%	+4.2%
Q4 25	13M	-1.3%	+1.7%
Q1 26	13M	-1.4%	+1.0%
Q2 26	13M	-1.6%	-3.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	$57.3K	900
Q4 21	$60.9K	900
Q1 22	$59.1K	900
Q2 22	$58.0K	900
Q3 22	$55.6K	900
Q4 22	$56.6K	900
Q1 23	$57.5K	900
Q2 23	$59.6K	900
Q3 23	$59.7K	900
Q4 24	$220.4K	222
Q1 25	$212.7K	222
Q2 25	$305.2K	222
Q3 25	$263.2K	222
Q4 25	$231.6K	238
Q1 26	$199.8K	238
Q2 26	$205.6K	238

Revenue / Employee